SNOA
Sonoma Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
SNOA fundamentals
Sonoma Pharmaceuticals (SNOA) released its earnings on Aug 7, 2025: revenue was 4.01M (YoY +18.40%), missed estimates; EPS was -0.3694 (YoY +70.80%), beat estimates.
Revenue / YoY
4.01M
+18.40%
EPS / YoY
-0.3694
+70.80%
Report date
Aug 7, 2025
EPS
Actual | -12.4 | -4.6825 | -4.5358 | -3.9825 | -1.1967 | -1.3779 | -1.2649 | -0.618 | -0.5945 | -0.152 | -0.3694 | ||||||||||||||||||
Forecast | -2.4 | -3.7763 | -4.1591 | -3.4082 | -1 | -0.8 | -0.69 | -0.73 | -0.51 | ||||||||||||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -88.99% | -5.46% | +71.23% | +59.57% | -26.49% | +22.75% | +13.84% | +79.18% | +27.57% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 2.94M | 3.01M | 3.43M | 2.73M | 3.14M | 3.44M | 3.39M | 3.58M | 3.56M | 3.75M | 4.01M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.38M | 3.60M | 3.76M | 3.98M | 3.78M | 3.82M | 4.06M | 4.44M | 4.05M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +1.41% | -24.04% | -16.57% | -13.50% | -10.34% | -6.40% | -12.21% | -15.44% | -0.86% |
Earnings Call
You can ask Aime
What were the key takeaways from Sonoma Pharmaceuticals's earnings call?Did Sonoma Pharmaceuticals beat or miss consensus estimates last quarter?What factors drove the changes in Sonoma Pharmaceuticals's revenue and profit?What guidance did Sonoma Pharmaceuticals's management provide for the next earnings period?What is Sonoma Pharmaceuticals's latest dividend and current dividend yield?What is the market's earnings forecast for Sonoma Pharmaceuticals next quarter?What is Sonoma Pharmaceuticals's gross profit margin?What does Sonoma Pharmaceuticals do and what are its main business segments?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
